216 related articles for article (PubMed ID: 18684217)
1. Effect of rosuvastatin on methionine-induced hyperhomocysteinaemia and haematological changes in rats.
Nigam GK; Ansari MN; Bhandari U
Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):287-92. PubMed ID: 18684217
[TBL] [Abstract][Full Text] [Related]
2. Ameliorative role of atorvastatin on methionine-induced hyperhomocysteinemia and hematological changes in albino rats.
Bhandari U; Pathan RA; Kumar V; Khanna N
Indian J Exp Biol; 2011 Feb; 49(2):132-9. PubMed ID: 21428215
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of Embelia ribes Burm on methionine-induced hyperhomocysteinemia and oxidative stress in rat brain.
Ansari MN; Bhandari U
Indian J Exp Biol; 2008 Jul; 46(7):521-7. PubMed ID: 18807756
[TBL] [Abstract][Full Text] [Related]
4. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
[TBL] [Abstract][Full Text] [Related]
5. Modulatory effect of curcumin on methionine-induced hyperlipidemia and hyperhomocysteinemia in albino rats.
Kapoor P; Ansari MN; Bhandari U
Indian J Exp Biol; 2008 Jul; 46(7):534-40. PubMed ID: 18807758
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
[TBL] [Abstract][Full Text] [Related]
7. Haematological evaluation of ethanolic extract of Allium ascalonicum in male albino rats.
Owoyele BV; Alabi OT; Adebayo JO; Soladoye AO; Abioye AI; Jimoh SA
Fitoterapia; 2004 Jun; 75(3-4):322-6. PubMed ID: 15158989
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins.
Gadarla M; Kearns AK; Thompson PD
Am J Cardiol; 2008 Jun; 101(12):1747-8. PubMed ID: 18549851
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of antioxidant defense mechanism by pitavastatin and rosuvastatin on obesity-induced oxidative stress in Wistar rats.
Ansari JA; Bhandari U; Haque SE; Pillai KK
Toxicol Mech Methods; 2012 Jan; 22(1):67-73. PubMed ID: 21859367
[TBL] [Abstract][Full Text] [Related]
10. Adding exercise training to rosuvastatin treatment: influence on serum lipids and biomarkers of muscle and liver damage.
Coen PM; Flynn MG; Markofski MM; Pence BD; Hannemann RE
Metabolism; 2009 Jul; 58(7):1030-8. PubMed ID: 19411087
[TBL] [Abstract][Full Text] [Related]
11. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
Kalaiarasi P; Kaviarasan K; Pugalendi KV
Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
[TBL] [Abstract][Full Text] [Related]
12. Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype.
Bermúdez-Pirela V; Souki A; Cano-Ponce C; Bermúdez-Arias F; Mengual-Moreno E; Leal-Gonzalez E; Lemus-Antepaz M; de Bravo MC; de Díaz AA; de Pirela NL; Cano-Peñaloza R; Puche-Medina G; Arraiz N; Reyna-Villazmil N; Contreras F; Israili ZH; Valasco M
Am J Ther; 2007; 14(2):213-20. PubMed ID: 17414592
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of rutin on lipids, lipoproteins, and ATPases in normal and isoproterenol-induced myocardial infarction in rats.
Stanely Mainzen Prince P; Karthick M
J Biochem Mol Toxicol; 2007; 21(1):1-6. PubMed ID: 17366541
[TBL] [Abstract][Full Text] [Related]
14. Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.
Ai M; Otokozawa S; Asztalos BF; Nakajima K; Stein E; Jones PH; Schaefer EJ
Am J Cardiol; 2008 Feb; 101(3):315-8. PubMed ID: 18237592
[TBL] [Abstract][Full Text] [Related]
15. Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.
Kostapanos MS; Milionis HJ; Lagos KG; Rizos CB; Tselepis AD; Elisaf MS
Eur J Pharmacol; 2008 Aug; 590(1-3):327-32. PubMed ID: 18585701
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin reduces gliosis and the accelerated weight gain observed in WT and ApoE-/- mice exposed to a high cholesterol diet.
Famer D; Crisby M
Neurosci Lett; 2007 May; 419(1):68-73. PubMed ID: 17433542
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
[TBL] [Abstract][Full Text] [Related]
18. Hypocholesterolemic effects of a flavonoid-rich extract of Hypericum perforatum L. in rats fed a cholesterol-rich diet.
Zou Y; Lu Y; Wei D
J Agric Food Chem; 2005 Apr; 53(7):2462-6. PubMed ID: 15796580
[TBL] [Abstract][Full Text] [Related]
19. Anti-atherogenic effects of seabuckthorn (Hippophaea rhamnoides) seed oil.
Basu M; Prasad R; Jayamurthy P; Pal K; Arumughan C; Sawhney RC
Phytomedicine; 2007 Nov; 14(11):770-7. PubMed ID: 17498939
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.
Kostapanos MS; Milionis HJ; Filippatos TD; Christogiannis LG; Bairaktari ET; Tselepis AD; Elisaf MS
J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):5-13. PubMed ID: 19246334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
